Summit Therapeutics (SMMT) Change in Intangibles (2017 - 2020)
Summit Therapeutics filings provide 4 years of Change in Intangibles readings, the most recent being -$168000.0 for Q3 2020.
- Quarterly Change in Intangibles fell 172.1% to -$168000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$168000.0 through Jun 2021, down 165.37% year-over-year, with the annual reading at $136000.0 for FY2019, N/A changed from the prior year.
- Change in Intangibles hit -$168000.0 in Q3 2020 for Summit Therapeutics, down from $4000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $233000.0 in Q3 2019 and bottomed at -$896492.0 in Q4 2017.
- Average Change in Intangibles over 4 years is -$102536.6, with a median of -$7000.0 recorded in 2018.
- The largest annual shift saw Change in Intangibles tumbled 1825.84% in 2019 before it plummeted 172.1% in 2020.
- Summit Therapeutics' Change in Intangibles stood at -$896492.0 in 2017, then soared by 100.74% to $6663.4 in 2018, then tumbled by 2261.07% to -$144001.2 in 2019, then decreased by 16.67% to -$168000.0 in 2020.
- Per Business Quant, the three most recent readings for SMMT's Change in Intangibles are -$168000.0 (Q3 2020), $4000.0 (Q2 2020), and $164000.0 (Q1 2020).